FDA.reportPublic FDA data

Reyataz 300 MG Oral Capsule

RxCUI
664743
RxNorm name
Reyataz 300 MG Oral Capsule
Display name
Reyataz 300 MG Oral Capsule
Full name
Reyataz 300 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
REYATAZATAZANAVIRE.R. Squibb & Sons, L.L.C.165cff62-b284-4a27-a65d-9ec8a5bfcdd82024-12-05Warnings, Adverse reactionsExact identifier
rxcui: 664743

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
165cff62-b284-4a27-a65d-9ec8a5bfcdd8Reyataz 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [Reyataz] [SBD] · Reyataz 300 MG Oral Capsule [SY]337These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ. REYATAZ ® (atazanavir) capsules, for oral use REYATAZ ® (atazanavir) oral powder Initial U.S. Approval: 200320241205
025876b6-f031-43ea-967a-b1d95b4685a6Reyataz 300 MG Oral Capsule [PSN] · atazanavir 300 MG Oral Capsule [Reyataz] [SBD] · Reyataz 300 MG Oral Capsule [SY]32These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ. REYATAZ ® (atazanavir sulfate) Capsules Initial U.S. Approval: 200320120217